AbbVie cues up filing for c-Met ADC in lung cancer

cafead

Administrator
Staff member
  • cafead   Nov 29, 2023 at 12:13: PM
via AbbVie is preparing to file for accelerated approval of telisotuzumab vedotin (Teliso-V) as a treatment for some patients with lung cancer after the drug hit the mark in a pivotal phase 2 trial.

article source